Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations-Reference-Cited by-同舟云学术

Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations

Published:2016-08-08 Issue:11 Volume:12 Page:1333-1341
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Savarino Edoardo¹,Martinucci Irene²,Furnari Manuele³,Romana Chiara³,Pellegatta Gaia³,Moscatelli Alessandro³,Bodini Giorgia³,Marabotto Elisa³,Savarino Vincenzo³,de Bortoli Nicola²,Blandizzi Corrado⁴

Affiliation:

1. Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy

2. Division of Gastroenterology, Department of Internal Medicine, University of Pisa, Pisa, Italy

3. Division of Gastroenterology, Department of Internal Medicine, University of Genoa, Genoa, Italy

4. Division of Pharmacology and Chemotherapy, University of Pisa, Pisa, Italy

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2016.1214714

Reference69 articles.

1. The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus

2. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?

3. Barrett's esophagus: proton pump inhibitors and chemoprevention II

4. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review

5. Review article: the pathophysiology of gastro-oesophageal reflux disease − oesophageal manifestations

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Comparison and Bioequivalence Evaluation of Two 20-mg Vonoprazan Fumarate Tablets in Bangladeshi Healthy Male Subjects;Journal of Biosciences and Medicines;2024

2. How safe are heartburn medications and who should use them?;Expert Opinion on Drug Safety;2023-07-21

3. Tiered approach to evaluate the CYP3A victim and perpetrator drug–drug interaction potential for vonoprazan using PBPK modeling and clinical data to inform labeling;CPT: Pharmacometrics & Systems Pharmacology;2023-03-10

4. Updates on Surgical Treatment for Gastroesophageal Reflux Disease;The American Surgeon™;2023-02-14

5. Vonoprazan for treatment of gastroesophageal reflux disease: Research advances;World Chinese Journal of Digestology;2021-11-08